Published in Int J Artif Organs on February 01, 1999
Chapter 14: Anti-glomerular basement membrane antibody glomerulonephritis. Kidney Int Suppl (2011) (2012) 0.83
Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption. PLoS One (2014) 0.82
Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol (2014) 0.82
Interventions for renal vasculitis in adults. A systematic review. BMC Nephrol (2010) 0.78
Outbreak of giardiasis: effect of a new antiflagellate drug, tinidazole. Br Med J (1972) 3.23
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
A randomized controlled trial oftransfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion (2001) 2.32
Retracted On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest (1991) 1.89
The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest (1985) 1.81
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol (1997) 1.70
Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand (1985) 1.65
Respiratory syncytial virus. An outbreak of acute respiratory illnesses in a home for infants. Acta Paediatr Scand (1966) 1.60
Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol (1989) 1.57
The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Transplant (2000) 1.56
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol (1993) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med (1990) 1.47
Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol (1995) 1.47
A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol (1988) 1.43
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol (1998) 1.40
Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Nephron (1989) 1.39
Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation (1988) 1.38
Twice-daily propranolol treatment for hypertension. Lancet (1971) 1.31
Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol (1985) 1.28
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol (1994) 1.26
The use of iohexol clearance to determine GFR in patients with severe chronic renal failure--a comparison between different clearance techniques. Clin Nephrol (1995) 1.24
A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest (2005) 1.20
Propranolol given twice daily in hypertension. Acta Med Scand (1973) 1.19
Smooth muscle antibodies in Mycoplasma pneumoniae infection. Clin Exp Immunol (1976) 1.17
Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.16
Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang (2009) 1.16
The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler). Eur Respir J (1989) 1.13
Long-term survival in transfusion recipients in Sweden, 1993. Transfusion (2001) 1.12
Renal replacement therapy in Sweden. Scand J Urol Nephrol (2004) 1.10
Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings. Acta Med Scand (1966) 1.09
Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest (1996) 1.08
Fifty uremic patients treated with renal homotransplantation. Scand J Urol Nephrol (1968) 1.08
The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest (1996) 1.07
Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Scand J Clin Lab Invest (1994) 1.07
Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation. Clin Exp Immunol (1974) 1.05
The influence of transphyseal drilling and tendon grafting on bone growth: an experimental study in the rabbit. J Pediatr Orthop (1998) 1.04
Effect of Mycoplasma pheumoniae infection on cell-mediated immunity. Infection (1976) 1.04
Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang (2008) 1.03
Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at -20 degrees C. Scand J Urol Nephrol (1997) 1.02
Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest (2007) 1.01
Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J Infect Dis (1987) 1.01
Living donor nephrectomy. Complication rates in 490 consecutive cases. Scand J Urol Nephrol (1992) 1.00
Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons. J Neuroimmunol (1991) 1.00
Evaluation of chemical and microscopical methods for mass detection of bacteriuria. Acta Med Scand (1969) 0.99
Acute dapsone intoxication: a case treated with continuous infusion of methylene blue, forced diuresis and plasma exchange. J Toxicol Clin Toxicol (1985) 0.99
Antibodies against Mycoplasma pneumoniae in bronchial secretions. Acta Pathol Microbiol Scand (1969) 0.98
Legionnaires' disease in leukaemic reticuloendotheliosis. Scand J Haematol (1980) 0.98
Bricanyl Turbuhaler and Ventolin Rotahaler in exercise-induced asthma in children. Allergy (1991) 0.97
Propranolol in hypertension. Report on 158 patients treated up to one year. Klin Wochenschr (1972) 0.97
Vertebral osteomyelitis after intravesical administration of bacille Calmette-Guérin. Clin Infect Dis (1994) 0.96
Acquired cytomegalovirus infection. Br Med J (1968) 0.96
Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis (1985) 0.96
[Giardiasis--a problem of current interest in Sweden]. Nord Med (1971) 0.96
The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol (1993) 0.96
Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation (1996) 0.95
Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet (1985) 0.95
Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange. J Neuroimmunol (1986) 0.95
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. Eur J Clin Pharmacol (1998) 0.94
Dyggve-Melchior-Clausen dysplasia. Morphological and biochemical findings in cartilage growth zones. Acta Paediatr Scand (1983) 0.94
[Giardiasis among Swedish tourists after a visit to the Soviet Union]. Lakartidningen (1972) 0.94
Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation (1995) 0.94
Acquired cytomegalovirus infection in older children and adults. A clinical study of hospitalized patients. Scand J Infect Dis (1970) 0.93
Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med (2004) 0.93
Fluorescent berberine binding as a marker of secretory activity in mast cells. Int Arch Allergy Appl Immunol (1983) 0.93
Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin. Nephron (1993) 0.93
Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol (1999) 0.92
Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron (1980) 0.92
World apheresis registry 2003-2007 data. Transfus Apher Sci (2008) 0.92
Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet (1989) 0.92
Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection. Acta Med Scand (1967) 0.92
The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol (1990) 0.90
Treatment of hypertension with propranolol and hydralazine. Acta Med Scand (1971) 0.89
In vitro lymphoproliferative assays with HgCl2 cannot identify patients with systemic symptoms attributed to dental amalgam. J Dent Res (1999) 0.89
Sexual risk behaviour and donor deferral in Europe. Vox Sang (2014) 0.89
Family history of renal stones in recurrent stone patients. Br J Urol (1985) 0.89
Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol (1986) 0.89
Transfusion of platelet concentrates--clinical evaluation of two preparations. Eur J Haematol (1996) 0.88
Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patients. Stroke (1983) 0.88
Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Report of two cases and review of the literature. Scand J Urol Nephrol (1997) 0.88
Chronic active hepatitis in children. A clinical and immunological long-term study. Acta Paediatr Scand (1977) 0.87
Denervated and intact kidney responses to saline load in awake and anesthetized dogs. Am J Physiol (1979) 0.87
Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. Hum Exp Toxicol (1994) 0.86
Biobanks of blood from donors and recipients of blood products. Vox Sang (2008) 0.86
Growth factor release during preparation and storage of platelet concentrates. Vox Sang (1995) 0.86
Exploring sex differences in case fatality in acute myocardial infarction or coronary death events in the northern Sweden MONICA Project. J Intern Med (2002) 0.86
IgG2 deficiency in primary Sjögren's syndrome and hypergammaglobulinemic purpura. Clin Immunol Immunopathol (1994) 0.86
EBV antibodies in family contacts of patients with infectious mononucleosis. Proc Soc Exp Biol Med (1970) 0.86
Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation. Arthritis Rheum (1996) 0.86
A comparison between Albustix, Hema-Combistix, Labstix, the sulphosalicyclic-acid test, Heller's nitric-acid test, and a biuret method. Diagnosis of proteinuria. Acta Med Scand (1969) 0.86
Terbutaline in COPD comparison between Turbuhaler and chlorofluorocarbon (CFC) inhaler. Lung (1994) 0.86
Respiratory syncytial virus in hospital cross-infection. Br Med J (1972) 0.85
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
Related donor kidney transplantation is the best form of treatment for uremia. Transplant Proc (1987) 0.85